Literature DB >> 10692836

Co-aggregation as a virulent factor of Streptococcus sanguis isolated from infective endocarditis.

K Ochiai1, K Kikuchi, K Fukushima, T Kurita-Ochiai.   

Abstract

The pathogenicity of strains of the Streptococcus sanguis group, isolated from infective endcarditis, was studied by measuring the development of subcutaneous abscesses in mice after infection with S. sanguis and Actinomyces viscosus either singly or as co-aggregated pairs. The pathogenicity of the co-aggregates was also examined in various viable combinations of the two bacterial species. More abscesses were formed by A. viscosus than the S. sanguis group including clinical isolates. Abscess formation by co-aggregates of combinations of each isolate and A. viscosus produced a higher percentage of abscess formation than those caused by infection with a pure suspension of A. viscosus or tested streptococci. Co-aggregated cells were more resistant to phagocytosis and killing by neutrophils in vivo. These results indicated that S. sanguis group streptococci isolated from infective endocarditis are able to co-aggregate and resist phagocytosis. The ability of co-aggregation of S. sanguis may serve as a survival mechanism in a host defense system and may be linked with virulence of this bacteria.

Entities:  

Mesh:

Year:  1999        PMID: 10692836     DOI: 10.2334/josnusd.41.117

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  2 in total

Review 1.  Disseminated coinfection with Actinomyces graevenitzii and Mycobacterium tuberculosis: case report and review of the literature.

Authors:  Andreas Tietz; Kenneth E Aldridge; Julio E Figueroa
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Probing prokaryotic social behaviors with bacterial "lobster traps".

Authors:  Jodi L Connell; Aimee K Wessel; Matthew R Parsek; Andrew D Ellington; Marvin Whiteley; Jason B Shear
Journal:  mBio       Date:  2010-10-12       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.